Elan Drug Delivery Sale

We have collected information about Elan Drug Delivery Sale for you. Follow the links to find out details on Elan Drug Delivery Sale.


Elan seeks fast sale of drug delivery unit-sources - Reuters

    https://www.reuters.com/article/elan-unit-idUSLC46247020080812
    Aug 12, 2008 · Ireland's Elan Corp has received first-round bids for its drug delivery unit and is hoping for a quick sale of the business, which may fetch as much as $1.3-1.4 billion, according to people...

UPDATE 2-Elan puts sale of drug delivery unit on hold ...

    https://www.reuters.com/article/elan-idUSN0910333820100809
    Aug 09, 2010 · Elan said it still aims to eventually sell the drug delivery unit, Elan Drug Technologies, but said market conditions are not conductive to an appropriate valuation. The company first tried to sell...

Elan Sells Drug Delivery Business to Alkermes for $960 in ...

    https://www.genengnews.com/topics/bioprocessing/elan-sells-drug-technologies-business-to-alkermes-for-960m-in-cash-and-shares/
    May 09, 2011 · Elan Sells Drug Technologies Business to Alkermes for $960M in Cash and Shares Merged entity will have scale and resources for investment in new products, Alkermes claims. Elan sold its Elan Drug...

Alkermes wraps buyout of Elan drug-delivery biz FiercePharma

    https://www.fiercepharma.com/drug-delivery/alkermes-wraps-buyout-of-elan-drug-delivery-biz
    Sep 19, 2011 · The provider of drug-delivery technologies has completed its buyout of Elan's drug-delivery business, made Ireland its new corporate home and revealed a new manufacturing deal with a top-10 pharma...

Elan mulls hiving-off drug delivery business again

    https://www.outsourcing-pharma.com/Article/2010/04/20/Elan-mulls-hiving-off-drug-delivery-business-again
    Irish drugmaker Elan has once again raised the possibility of selling its delivery business, Elan Drug Technologies (EDT). The move would establish Elan BioNeurology and EDT as separate entities with, according to analysts quoted by the Wall Street Journal ​, the latter being valued at around $950m …

Alkermes, Elan deal forms well-positioned drug delivery ...

    https://www.fiercepharma.com/drug-delivery/alkermes-elan-deal-forms-well-positioned-drug-delivery-company
    May 11, 2011 · Elan Drug Technologies' merger with Alkermes seems to be a good thing all around for the future of both their drug-delivery technologies. Just to …

Elan Drug Technologies – World's Leading Drug Delivery ...

    http://www.pharmtech.com/elan-drug-technologies-%e2%80%93-worlds-leading-drug-delivery-business
    Mar 26, 2010 · Since 2001, 12 products have been approved and launched in the US alone incorporating their technologies, making Elan Drug Technologies, in terms of product launches, the most successful drug delivery company of the decade. To date Elan’s drug delivery technologies have been commercialised in 36 products in more than 100 countries worldwide.

Recent technologies in pulsatile drug delivery systems

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548250/
    Jul 01, 2011 · Pulsatile drug delivery systems (PDDS) have attracted attraction because of their multiple benefits over conventional dosage forms. They deliver the drug at the right time, at the right site of action and in the right amount, which provides more benefit than …Author: Deepika Jain, Richa Raturi, Vikas Jain, Praveen Bansal, Ranjit Singh

Elan goes beyond delivery tech with oral solid dose service

    https://www.outsourcing-pharma.com/Article/2010/09/21/Elan-goes-beyond-delivery-tech-with-oral-solid-dose-service
    Elan Drug Technologies (EDT) says new bespoke oral solid dose (OSD) service will take its contract manufacturing business beyond drug delivery. The service, which will be premiered at CPhI 2010 in Paris, will cover all aspects of OSD development and production and allow customers to tailor manufacturing according to specific requirements.

Financial climate better for potential delivery unit sale ...

    https://www.biopharma-reporter.com/Article/2010/06/01/Financial-climate-better-for-potential-delivery-unit-sale-says-Elan
    The drug delivery unit’s performance in the first three months of 2010 must also be a factor in Elan’s optimism about finding a buyer this time around. Drug delivery revenue for the quarter ended March 31 reached $76.4m (€61.5m), up 27 per cent on the comparable period in 2009, driven, according to Elan, by Acorda Therapeutics’ launch ...

Searching for Elan Drug Delivery Sale?

You can just click the links above. The data is collected for you.

Related Delivery Info